GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zelluna ASA (OSTO:ULTIo) » Definitions » Net Interest Income (for Banks)

Zelluna ASA (OSTO:ULTIO) Net Interest Income (for Banks)


View and export this data going back to 2019. Start your Free Trial

What is Zelluna ASA Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


Zelluna ASA Business Description

Industry
Traded in Other Exchanges
Address
Ullernchausseen 64, Oslo, NOR, 0379
Zelluna ASA is a clinical-stage biotechnology company developing novel immunotherapies against cancer and the development of T-Cell Receptor Natural Killer cell therapies for the treatment of solid cancers. The company's current pipeline consists of allogeneic TCR-NK R&D programs ZI-MA4-1, ZI-KL1-1, and ZI-PR-1 targeting well validated antigens expressed across a broad range of solid tumors.